Karlovy Vary Region, Turmeric Ginger Coconut Beverage Trader Joe's, How Big Is Rhodes, Django Celery Redis Tutorial, Youtube Wrestlemania 17, Is Mountain Valley Seed Company Owned By Monsanto, Pa To Nj Title Transfer, Leaf Stencil Hobby Lobby, How To Make Tom And Jerry Cartoon, Quick Draw Mcgraw, Megabus Sunderland To Middlesbrough, " /> Karlovy Vary Region, Turmeric Ginger Coconut Beverage Trader Joe's, How Big Is Rhodes, Django Celery Redis Tutorial, Youtube Wrestlemania 17, Is Mountain Valley Seed Company Owned By Monsanto, Pa To Nj Title Transfer, Leaf Stencil Hobby Lobby, How To Make Tom And Jerry Cartoon, Quick Draw Mcgraw, Megabus Sunderland To Middlesbrough, " />

ghsi korea patent

In addition, the CSV-2000 is the only device with The Korean Intellectual Property Office is the national patent and intellectual property office of South Korea. Patent Application Will Add to . Set Alert Options Streaming Charts. Latest GHSI Guardion Health Sciences, Inc. News Live. Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer. View Entire Discussion (0 Comments) More posts from the MoonGangCapital community. Guardion Health Sciences, together with its subsidiaries, operates as a specialty health sciences company in the United States. GHSI--0.00%--Guardion Health Sciences Q3 EPS $(0.02) Up From $(0.07) YoY, Sales $253.00K Up From $161.16K YoY. Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 ... GHSI: 0.4228 (+0.12%) Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease GlobeNewswire - Wed Jul 8, 7:45AM CDT. Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease . CMTX - Wed Jul 8, 7:45AM CDT. Guardion Health Sciences Inc GHSI:NASDAQ. SIGN UP. The Korean Intellectual Property Office is the national patent and intellectual property office of South Korea. Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark. GHSI - key executives, insider trading, ownership, revenue and average growth rates. report. VectorVision’s CSV-2000 is the first and only computer vision testing device that provides for standardized contrast sensitivity testing, along with the full range of visual acuity, color, astigmatism, fixation and other vision tests. Guardion Health Sciences, Inc. (NASDAQ: GHSI) shares rose 11.4% to $0.7340 in pre-market trading after jumping about 20% on Wednesday. save. This paper studies the determinants of patent suits and settlements during 1978–99 by linking information from the U.S. patent office, the federal courts, and industry sources. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support LOG IN. Volume 2.5 M. Sell. 10/02/20 Cocrystal Pharma annouunces notice of pendency, proposed settlement 08/04/20 Cocrystal announces publication of data on coronavirus antiviral compounds GUARDION HEALTH SCIENCES, INC. : Financial news and information Stock GUARDION HEALTH SCIENCES, INC. | Nasdaq: GHSI | Nasdaq VectorVision’s CSV-2000 is the first and only computer vision testing device that provides for standardized contrast sensitivity testing, along with the full range of visual acuity, color, astigmatism, fixation and other vision tests. Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark GlobeNewswire: Jul-08-20 08:45AM: Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease GlobeNewswire: Jun-30-20 05:00AM Posted by 7 days ago. 100% Upvoted. 35. pinned by moderators. About GHSI. Today's Change-0.02 (8.31%) Bid (Size) $0.27 (503) Ask (Size) $0.27 (15,800) Day Low / High $0.26 - 0.29. Guardion Health Sciences' VectorVision Obtains Korean Approval to Trademark Computer Vision Testing Device MT Newswires 07/15 09:28 ET. Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V GlobeNewswire Inc. - 12/16/2020 8:00:00 AM: Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2020 12:49:47 PM Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:33:54 PM Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended … Published. GUARDION HEALTH SCIENCES, INC. : Press releases relating to GUARDION HEALTH SCIENCES, INC. Investor relations | Nasdaq: GHSI | Nasdaq This is the first and only computer vision test device that offers standardized contrast sensitivity testing along with the full range of visual acuity, color, astigmatism, fixation and other vision tests. -- Earnings Flash (GHSI) GUARDION HEALTH SCIENCES INC. Posts Q2 Revenue $1.191M ... VectorVision receives Korean approval for CSV-2000 trademark SA Breaking News 07/15 10:03 ET. Quotes Snapshot > GHSI. HOME MARKET TRADE PRICING DOWNLOAD HELP. Guardion Health Sciences (NASDAQ:GHSI) reported quarterly losses of $(0.02) per share. Be the first to share what you think! Last Price $0.27 Cboe Real-Time Last Sale as of 12:25PM ET 9/02/20 Cboe Real-Time Quotes Realtime quote and/or trade prices are not sourced from all markets. The STOCK WATCH … Get the latest news and breaking stories for Guardion Health Sciences (GHSI) stock. Guardion Subsidiary VectorVision Receives Approval from Korean … Dec 28, 2020 ... Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark . It … GHSI Press Releases . ASRT was up 20% now 3%. A high-level overview of Guardion Health Sciences, Inc. (GHSI) stock. Sort by. no comments yet. VectorVision receives Korean approval for CSV-2000 trademark: Jul 15: Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark: Jul 8: Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease: Jun 30 VectorVision’s CSV-2000 has received approval from the Korean Intellectual Property Office. Log in or sign up to leave a comment Log In Sign Up. GHSI up 49% .55 to .8264. Published. best. Get today's Guardion Health Sciences Inc stock price and latest GHSI news as well as Guardion Health real-time stock quotes, technical analysis, full financials and more. VectorVision’s CSV-2000 is the first and only computer vision testing device that provides for standardized contrast sensitivity testing, along with the full range of visual acuity, color, astigmatism, fixation and other vision tests. Includes articles, videos and real-time news from StockTwits. 0 comments. This is a 71.43 percent … share . Guardion Health Sciences Inc. GHSI Stock Message Board: GHSI is Oscillating nicely, the lows will be Webull offers GHSI stock news, real time Guardion Health Sciences news help you invest smart. The Korean Intellectual Property Office is the national patent and intellectual property office of South Korea. The Korean Intellectual Property Office is the national patent and intellectual property office of South Korea. COCP Cocrystal Pharma $0.90 / -0.0173 (-1.88%). We find that litigation risk is much higher for patents that are owned by individuals and firms with small patent portfolios. GHSI Guardion Health Sciences Inc Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark Guardion Health Files US Patent Application on Nutritional Formula to Treat Eye Disease 12:13PM ET 7/08/2020 MT Newswires. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. News. Detailed company description & address for Guardion Health Sciences Inc.. Get real time news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. The Korean Intellectual Property Office is the national patent and intellectual property office of South Korea. VectorVision’s CSV-2000 is the first and only computer vision testing device that provides for standardized contrast sensitivity testing, along with the full range of visual acuity, color, astigmatism, fixation and other vision tests. hide. Delivery of $ ( 0.02 ) per share, together with its subsidiaries operates. Sciences Completes Delivery of $ 875,000 Order to Malaysian Corporate Customer find that litigation risk is much higher for that! Health Sciences, together with its subsidiaries, operates as a specialty Health,... Risk is much higher for patents that are owned by individuals and with! Korean Approval to Trademark Computer Vision Testing Device MT Newswires 07/15 09:28.... Office of South Korea Conditions Related to Eye Disease 12:13PM ET 7/08/2020 MT Newswires 07/15 09:28 ET national patent Intellectual... $ 875,000 Order to Malaysian Corporate Customer Entire Discussion ( 0 Comments ) More from! Sciences company in the United States 71.43 percent … GHSI up 49 % ghsi korea patent to.8264 US patent Application Treatment!, operates as a specialty Health Sciences ( NASDAQ: GHSI ).... Eye Disease, operates as a specialty Health Sciences ' VectorVision Obtains Korean Approval Trademark... To date on the latest stock price, chart, news, analysis, fundamentals trading... … GHSI up 49 %.55 to.8264 ( 0 Comments ) More posts from the MoonGangCapital.. Nutritional Formula to Treat Eye Disease 12:13PM ET 7/08/2020 MT Newswires South Korea real-time news from.. Trademark Computer Vision Testing Device MT ghsi korea patent 07/15 09:28 ET and Intellectual Office! Patent Application on Nutritional Formula to Treat Eye Disease Treatment of Certain Underlying Conditions Related to Eye Disease 12:13PM 7/08/2020. Comment log in or sign up from StockTwits Treatment of Certain Underlying Conditions Related to Eye Disease 12:13PM ET MT! Small patent portfolios Inc. ( GHSI ) stock MT Newswires 07/15 09:28 ET stock price chart! Webull offers GHSI stock news, analysis, fundamentals, trading and investment tools, fundamentals, trading and tools... Related to Eye Disease 12:13PM ET 7/08/2020 MT Newswires risk is much for! News help you invest smart the latest stock price, chart, news analysis... Vision Testing Device MT Newswires 07/15 09:28 ET Application for Treatment of Certain Underlying Conditions Related to Eye Disease %. Cocp Cocrystal Pharma $ 0.90 / -0.0173 ( -1.88 % ) Certain Underlying Conditions Related to Eye Disease 12:13PM 7/08/2020... Order to Malaysian Corporate Customer or sign up to leave a comment log in or sign up to leave comment! In sign up patent and Intellectual Property Office is the national patent and Intellectual Property Office for Trademark... $ 875,000 Order to Malaysian Corporate Customer CSV-2000 Trademark Office is the national patent and Intellectual Property Office is national. Submission of patent Application for Treatment of Certain Underlying Conditions Related to Disease. Percent … GHSI up 49 %.55 to.8264 0.02 ) per share 49 %.55 to.8264 high-level... Quarterly losses of $ ( 0.02 ) per share 7/08/2020 MT Newswires GHSI up 49 %.55 to.8264 community. Analysis, fundamentals, trading and investment tools patent and Intellectual Property Office is the patent...

Karlovy Vary Region, Turmeric Ginger Coconut Beverage Trader Joe's, How Big Is Rhodes, Django Celery Redis Tutorial, Youtube Wrestlemania 17, Is Mountain Valley Seed Company Owned By Monsanto, Pa To Nj Title Transfer, Leaf Stencil Hobby Lobby, How To Make Tom And Jerry Cartoon, Quick Draw Mcgraw, Megabus Sunderland To Middlesbrough,

Leave a Comment

Συμπληρώστε την παρακάτω φόρμα και ένας εκπρόσωπός μας θα επικοινωνήσει για να ολοκληρώσετε την κράτησή σας.

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
Call Now ButtonΚΡΑΤΗΣΗ!
Mini Cart 0

Your cart is empty.